Cargando…

Monitoring and Improving Naltrexone Adherence in Patients with Substance Use Disorder

OBJECTIVE: Naltrexone is an opioid antagonist used for the treatment of patients with opioid use disorder and alcohol use disorder. This population often presents problems of follow-up and therapeutic efficacy related to adherence to treatment. The purpose of our study is to provide an exhaustive su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perez-Macia, Virginia, Martinez- Cortes, Mireia, Mesones, Jesus, Segura-Trepichio, Manuel, Garcia-Fernandez, Lorena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140930/ https://www.ncbi.nlm.nih.gov/pubmed/34040354 http://dx.doi.org/10.2147/PPA.S277861

Ejemplares similares

Randomized Controlled Trial of a Mobile Phone Intervention for Improving Adherence to Naltrexone for Alcohol Use Disorders
por: Stoner, Susan A., et al.
Publicado: (2015)

Naltrexone Implant for Opioid Use Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)

Use of Naltrexone in Internet Gaming Disorder
por: Gour, Rahul, et al.
Publicado: (2022)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence
por: Wang, A-L, et al.
Publicado: (2015)

Treatment outcomes of long-acting injectable naltrexone versus oral naltrexone in alcohol use disorder in veterans
por: Leighty, Anne E., et al.
Publicado: (2019)

The Potential Role of Naltrexone in Borderline Personality Disorder
por: Moghaddas, Azadeh, et al.
Publicado: (2017)

Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities
por: Qeadan, Fares, et al.
Publicado: (2021)

O-Benzoylnaltrexone
por: Yang, Rui, et al.
Publicado: (2013)

Asymmetric synthesis of (–)-naltrexone
por: Dongbang, Sun, et al.
Publicado: (2018)

Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone
por: Colquhoun, Ross M.
Publicado: (2013)

Behavioral and Accumbal Responses During an Affective Go/No-Go Task Predict Adherence to Injectable Naltrexone Treatment in Opioid Use Disorder
por: Shi, Zhenhao, et al.
Publicado: (2019)

Naltrexone-induced psychosis in a patient with alcohol use disorder
por: Ruei-Yuan, Hu, et al.
Publicado: (2023)

Naltrexone‐induced drug eruption
por: Heck, Johannes, et al.
Publicado: (2020)

Naltrexone and the Treatment of Alcohol Dependence
por: Volpicelli, Joseph R., et al.
Publicado: (1994)

Effects of Naltrexone on Large-Scale Network Interactions in Methamphetamine Use Disorder
por: Kohno, Milky, et al.
Publicado: (2019)

Length of stay, costs, and complications in lumbar disc herniation surgery by standard PLIF versus a new dynamic interspinous stabilization technique
por: Segura-Trepichio, Manuel, et al.
Publicado: (2017)

Role of Naltrexone in Improving Compulsive Drinking in Psychogenic Polydipsia
por: Rizvi, Sukaina, et al.
Publicado: (2019)

Methylnaltrexone bromide methanol monosolvate
por: Li, Guoqing, et al.
Publicado: (2012)

Naltrexone: A History and Future Directions
por: Srivastava, A. Benjamin, et al.
Publicado: (2018)

Low-Dose Naltrexone in Rheumatological Diseases
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2023)

Primary Sacral Hydatid Cyst Mimicking a Neurogenic Tumor in Chronic Low Back Pain: Case Report and Review of the Literature
por: Segura-Trepichio, Manuel, et al.
Publicado: (2016)

Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review
por: Dahlberg, Sarah, et al.
Publicado: (2022)

NALTREXONE IN PRIMARY HYPERPHAGIC OBESITY WITY HYPOCHONDRIACAL DISORDER - A CLINICAL STUDY
por: Pandey, Ravi S., et al.
Publicado: (1999)

Adding Psychotherapy to the Naltrexone Treatment of Alcohol Use Disorder: Meta-analytic Review
por: Ahmed, Rizwan, et al.
Publicado: (2018)

Effectiveness of naltrexone treatment for alcohol use disorders in HIV: a systematic review
por: Farhadian, Negin, et al.
Publicado: (2020)

Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease
por: Ayyala, Divya, et al.
Publicado: (2022)

Low-Dose Naltrexone for Pruritus in Systemic Sclerosis
por: Frech, Tracy, et al.
Publicado: (2011)

Combination of Naltrexone and Isotretinoin for the Treatment of Darier Disease
por: Costa, Tomás, et al.
Publicado: (2023)

Effects of genotype and food on naltrexone exposure in adolescents
por: Stancil, Stephani L., et al.
Publicado: (2022)

Naltrexone-induced acute generalized exanthematous pustulosis
por: Eakes, Jason, et al.
Publicado: (2023)

Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use
por: Xu, Kevin Y., et al.
Publicado: (2022)

FMRI-based prediction of naltrexone response in alcohol use disorder: a replication study
por: Bach, Patrick, et al.
Publicado: (2021)

Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans
por: Maqueda, Ana Elda, et al.
Publicado: (2016)

Thermosensitive Gels Used to Improve Microneedle-Assisted Transdermal Delivery of Naltrexone
por: Tobin, Kevin V., et al.
Publicado: (2021)

Evaluating the Impact of Naltrexone on the Rat Gambling Task to Test Its Predictive Validity for Gambling Disorder
por: Di Ciano, Patricia, et al.
Publicado: (2016)

Medication Treatment for Opioid Use Disorders:: A Brief Overview with Comments on Extended Release Naltrexone
por: Woody, George
Publicado: (2017)

Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical Outcomes
por: Kirchoff, Robert W., et al.
Publicado: (2021)

Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey
por: Leung, Jonathan G., et al.
Publicado: (2022)

Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone
por: Marciuch, Anne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_441me42g6dj19c2dv1b51bgove